콘텐츠로 건너뛰기
Merck
  • Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.

Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.

Drug development and industrial pharmacy (2009-08-07)
Sumio Chono, Keita Kaneko, Eri Yamamoto, Kohei Togami, Kazuhiro Morimoto
초록

The effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages (AMs) was evaluated in vitro and in vivo. 4-Aminophenyl-α-D-mannopyranoside (Man) was used for surface-mannose modification, and mannosylated liposomes with various mannosylation rates (particle size: 1000 nm) were prepared. In the in vitro uptake experiments, the uptake of mannosylated liposomes by AMs was increased with the increase in the mannosylation rate over the range 2.4-9.1 mol% Man and became constant at over 9.1%. Thus, the most efficient mannosylation rate was 9.1 mol% Man. Furthermore, free mannose inhibited the uptake of mannosylated liposomes by AMs. This indicates that the uptake mechanism of mannosylated liposomes by AMs is mannose receptor-mediated endocytosis. In the in vivo animal experiments, the mannosylated liposomes (mannosylation rate, 9.1 mol% Man) were more efficiently delivered to AMs after pulmonary aerosolization to rats than nonmodified liposomes and did not harm lung tissues. These results indicate that surface-mannose modification is useful for efficient aerosolized liposomal delivery to AMs.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
4-Aminophenyl α-D-mannopyranoside, ≥98% (TLC)